‘Biosimilar’ Insulin Glargine, Semglee, Authorised for Diabetes in US

Semglee, a protracted-acting human insulin analogue, has been well-liked for glycemic management in adults and kids with sort 1 diabetes and adults with sort 2 diabetes, the Meals and Drug Administration announced June 11. “Long-acting insulin products esteem insulin glargine play…